polypeptide hormone
Calcitonin
Answer
Calcitonin is authorised or registered in the US, the UK, Canada, Australia, Switzerland, Brazil, Singapore and Turkey: 8 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 154 registered trials, 25 of them running. Brand names on the FDA label register: Calcitonin Salmon, Osteobios, Miacalcin and Guna-Arthro.
RegulatorTrial register10 regulators' registers, read 2026-09-03 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
154 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 15 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 70 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Withdrawn | EMA, ema | 2026-10-03 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Registered | TGA, au-artg | 2026-10-03 |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-10-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Registered | HSA, sg-hsa | 2026-09-03 |
| Turkey | Ruhsatli | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Calcitonin changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 154 trials
| NCT03401619 | Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study running, but no longer enrolling · register updated 2026-10-02 |
|---|---|
| 2022-502922-41-00 | Long-term safety and efficacy of semaglutide s.c. once-weekly on weight management in children and adolescents (aged 6 to <18 year no status recorded · register updated 2026-10-01 |
| NCT05955612 | Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults completed · register updated 2026-09-22 |
| NCT07599228 | Using Virtual Reality to Teach Mindfulness to People With Migraine not yet recruiting participants · register updated 2026-08-26 |
| NCT01498705 | The Natural History of Procalcitonin in Hemorrhagic Stroke withdrawn before enrolling anyone · register updated 2026-08-21 |
| NCT07769255 | Effect of Nebulized Dexmedetomidine on Central Sensitization and Chronification in Migraine currently recruiting participants · register updated 2026-08-17 |
| NCT07699549 | Long-term Atogepant in Real-world Practice completed · register updated 2026-07-22 |
| NCT07699432 | Different Kinematics Within a Single-File System and Postoperative Pain running, but no longer enrolling · register updated 2026-07-13 |
| NCT07655804 | Subcutaneous Calcitonin in Acute Herpes Zoster currently recruiting participants · register updated 2026-07-06 |
| NCT07653516 | Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness not yet recruiting participants · register updated 2026-07-01 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.